RxDoctor Payments Data

Katrina Smith, MD

Dermatology · Ankeny, IANPI 1104859040

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.7% of the total across 392 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,386, more than ten times the $49 reported in 2020. Among dermatology clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,818in general payments, 2019–2025

Across 392 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Sun Pharmaceutical Industries Inc.$968
  • Lilly USA, LLC$657
  • Johnson & Johnson$547
  • Amgen$394
  • UCB, Inc.$370
  • plus $3K from 18 others

What the payments were for

  • Food & beverage$6,52396%
  • Education$2944%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,818 in reported general payments places this provider in the 90th percentile of 92 dermatology providers in Iowa.

See all dermatology providers in Iowa

Medicare billing

Part B allowed, 2024
$250,268
Medicare patients
855
Services billed
4,249

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Betamethasone Dipropionate186$6,636
Fluorouracil30$2,447
Clobetasol Propionate67$2,335
Metronidazole37$1,783
Ketoconazole121$1,569
Tacrolimus14$1,421
Triamcinolone Acetonide226$1,063
Dutasteride46$1,035
ValacyclovirValacyclovir Hcl24$962
Doxycycline Hyclate56$878
Fluocinonide24$700
MethotrexateMethotrexate Sodium17$506
Finasteride33$494
Clindamycin Phosphate13$481
Hydroxychloroquine Sulfate17$464

Paid to pharmacies, not to this prescriber.

Other dermatology in Ankeny

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →